The objective of the PReDicT Project (Predicting Response to Depression Treatment) is to conduct clinical, health economic and commercial research to validate the clinical performance and to complete the pre-commercial development of the P1vital® PReDicT Test, a novel medical device to improve the treatment and management of depression in clinical practice. On completion of the PReDicT Project, the P1vital® PReDicT Test will be ready for market launch.



Horizon 2020 Emblem